Shawn Dason1, Alvin C Goh. 1. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Abstract
PURPOSE OF REVIEW: Robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) is being increasingly performed worldwide. This review summarizes recent technical developments and outcome data for RARC with ICUD. RECENT FINDINGS: With the recent description of intracorporeal continent cutaneous diversion, all classes of urinary diversion can presently be performed totally intracorporeally. The summary of our seven cases of intracorporeal continent cutaneous diversion in this article brings the number of reported cases in the literature to 17. Additional recent advancements in ICUD focus on novel technical descriptions and outcome data. Several intracorporeal orthotopic ileal neobladder techniques have been described with intermediate perioperative outcomes. There is some rationale for reduced overall, wound, gastrointestinal and genitourinary complications with ICUD. SUMMARY: RARC with intracorporeal diversion is a feasible option for patients with bladder cancer. Prospective and randomized outcome data are needed to better characterize the benefit of ICUD in patients following radical cystectomy.
PURPOSE OF REVIEW: Robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) is being increasingly performed worldwide. This review summarizes recent technical developments and outcome data for RARC with ICUD. RECENT FINDINGS: With the recent description of intracorporeal continent cutaneous diversion, all classes of urinary diversion can presently be performed totally intracorporeally. The summary of our seven cases of intracorporeal continent cutaneous diversion in this article brings the number of reported cases in the literature to 17. Additional recent advancements in ICUD focus on novel technical descriptions and outcome data. Several intracorporeal orthotopic ileal neobladder techniques have been described with intermediate perioperative outcomes. There is some rationale for reduced overall, wound, gastrointestinal and genitourinary complications with ICUD. SUMMARY: RARC with intracorporeal diversion is a feasible option for patients with bladder cancer. Prospective and randomized outcome data are needed to better characterize the benefit of ICUD in patients following radical cystectomy.
Authors: Matthew B Clements; Caroline C Gmelich; Emily A Vertosick; Jim C Hu; Jaspreet S Sandhu; Peter T Scardino; James A Eastham; Vincent P Laudone; Karim A Touijer; Jonathan A Coleman; Andrew J Vickers; Behfar Ehdaie Journal: Cancer Date: 2021-11-01 Impact factor: 6.860
Authors: Ji Sung Shim; Tae Gyun Kwon; Koon Ho Rha; Young Goo Lee; Ji Youl Lee; Byong Chang Jeong; Jong Hyun Pyun; Sung Gu Kang; Seok Ho Kang Journal: Investig Clin Urol Date: 2019-12-18
Authors: Satoshi Katayama; Keiichiro Mori; Benjamin Pradere; Hadi Mostafaei; Victor M Schuettfort; Fahad Quhal; Reza Sari Motlagh; Ekaterina Laukhtina; Marco Moschini; Nico C Grossmann; Yasutomo Nasu; Shahrokh F Shariat; Harun Fajkovic Journal: Int J Clin Oncol Date: 2021-06-19 Impact factor: 3.402